Ibrutinib and Posaconazole: Drug Interaction Guide

Quick answer: This is a major interaction — avoid combining Ibrutinib and Posaconazole unless specifically directed by your doctor.

Interaction severity: Major — avoid combination

How Ibrutinib interacts with Posaconazole

Posaconazole strongly inhibits CYP3A4, substantially increasing ibrutinib exposure and the risks of bleeding, arrhythmia, and other concentration-dependent toxicity.

What you should do

Avoid the combination when possible. If posaconazole is essential, interrupt or reduce ibrutinib according to its prescribing guidance and monitor closely for toxicity.

Key facts

Severity

Major — avoid combination

Mechanism

Posaconazole strongly inhibits CYP3A4, substantially increasing ibrutinib exposure and the risks of bleeding, arrhythmia...

Action

Avoid the combination when possible. If posaconazole is essential, interrupt or reduce ibrutinib according to its prescr...

Important medical disclaimer: This page provides educational information about drug interactions for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your specific medications with a qualified healthcare provider before starting, stopping, or changing any treatment. About our editorial team.

Frequently asked questions

Can I take Ibrutinib and Posaconazole together?

No — this combination should generally be avoided. Avoid the combination when possible. If posaconazole is essential, interrupt or reduce ibrutinib according to its prescribing guidance and monitor closely for toxicity.

What is the severity of this interaction?

The interaction between Ibrutinib and Posaconazole is classified as Major — avoid combination. Posaconazole strongly inhibits CYP3A4, substantially increasing ibrutinib exposure and the risks of bleeding, arrhythmia, and other concentration-dependent toxicity.

What should I do if I'm prescribed both?

Avoid the combination when possible. If posaconazole is essential, interrupt or reduce ibrutinib according to its prescribing guidance and monitor closely for toxicity. Always consult your prescribing clinician — do not stop or change medications without medical guidance.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.